News
The AVROBIO-sponsored Phase 2 trial of AVR-RD-01 (the FAB-201 Study 1) is an open-label, single-arm clinical trial evaluating the efficacy and safety of AVR-RD-01 in eight to twelve treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback